Tyrosine kinase inhibitors

Tyrosine kinase inhibitors, abbreviated TKIs, are a group of drugs that inhibit the action of tyrosine kinases.

The category includes many cancer drugs - including:

• Imatinib (Gleevec).
• Gefitinib (Iressa).
• Erlotinib (Tarceva).

See also

• Epidermal growth factor receptor inhibitors.
• Cancer drugs.
• Lung adenocarcinoma.